S. Nancy Lurker's most recent trade in EyePoint Pharmaceuticals Inc was a trade of 11,111 Common Stock done . Disclosure was reported to the exchange on July 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 11,111 | 216,547 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 11,111 | 11,112 | - | - | Restricted Stock Units | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2025 | 103,308 | 178,442 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2025 | 103,308 | 272,358 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2025 | 55,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2025 | 55,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2025 | 31,165 | 0 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2025 | 31,165 | 213,700 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2025 | 27,270 | 49,730 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2025 | 27,270 | 27,270 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2025 | 15,278 | 31,944 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2025 | 15,278 | 34,722 | - | - | Stock Option (Right to Buy) | |
| Alkermes plc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 8,013 | 12,629 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 8,013 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Nancy S. Lurker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.61 per share. | 31 May 2025 | 1,924 | 10,705 (0%) | 0% | 30.6 | 58,894 | Ordinary Shares |
| Alkermes plc | Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 13,474 | 13,474 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 6,142 | 6,142 | - | - | Restricted Stock Unit Award | |
| Collegium Pharmaceutical Inc | Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 9,791 | 22,517 (0%) | 0% | 0 | Common Stock | |
| Alkermes plc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2025 | 3,752 | 5,517 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2025 | 3,752 | 7,503 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2025 | 2,323 | 2,323 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2025 | 2,323 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Nancy S. Lurker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.00 per share. | 11 Apr 2025 | 901 | 4,616 (0%) | 0% | 27 | 24,327 | Ordinary Shares |
| Alkermes plc | Nancy S. Lurker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.00 per share. | 11 Apr 2025 | 558 | 1,765 (0%) | 0% | 27 | 15,066 | Ordinary Shares |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 20,000 | 0 | - | - | Restricted Stock Units | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 20,000 | 205,436 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 12,726 | 12,726 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 75,134 | 185,436 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 75,134 | 75,133 | - | - | Restricted Stock Units | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 12,667 | 25,333 | - | - | Restricted Stock Units | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 12,667 | 110,302 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Purchase of securities on an exchange or from another person at price $ 7.88 per share. | 16 Aug 2024 | 3,173 | 97,635 (0%) | 0% | 7.9 | 25,003 | Common Stock |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jul 2024 | 56,350 | 169,050 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jul 2024 | 56,350 | 281,750 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jul 2024 | 30,000 | 145,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jul 2024 | 30,000 | 95,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jul 2024 | 26,713 | 182,535 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jul 2024 | 26,713 | 31,165 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jul 2024 | 16,666 | 16,666 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jul 2024 | 16,666 | 50,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jul 2024 | 1,558 | 0 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jul 2024 | 1,558 | 74,800 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2024 | 11,111 | 94,462 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2024 | 11,111 | 22,223 | - | - | Restricted Stock Units | |
| Alkermes plc | Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,492 | 17,492 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 8,013 | 8,013 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2024 | 22,103 | 22,103 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2024 | 11,255 | 11,255 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2024 | 4,833 | 4,833 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2024 | 2,323 | 2,323 | - | - | Restricted Stock Unit Award | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 74,681 | 126,889 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 74,681 | 83,351 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharmaceuticals Inc | Lurker Nancy S. | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| EyePoint Pharmaceuticals Inc | S. Nancy Lurker | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 20,000 | 155,441 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 17,534 | 0 | - | - | Restricted Stock Units | |
| EyePoint Pharmaceuticals Inc | Nancy Lurker S. | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 17,534 | 172,975 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharmaceuticals Inc | Lurker S. Nancy | Director, Executive Vice Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.80 per share. | 09 Feb 2024 | 7,962 | 165,013 (0%) | 0% | 28.8 | 229,306 | Common Stock |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, Executive Vice Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.80 per share. | 09 Feb 2024 | 6,981 | 158,032 (0%) | 0% | 28.8 | 201,053 | Common Stock |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 5,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Lurker S. Nancy | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 5,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Lurker S. Nancy | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 4,452 | 155,822 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy Lurker S. | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 4,452 | 57,878 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | S. Lurker Nancy | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 3,116 | 1,558 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Lurker S. Nancy | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 3,116 | 73,242 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | S. Lurker Nancy | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Jan 2024 | 112,700 | 112,700 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | S. Lurker Nancy | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Jan 2024 | 112,700 | 338,100 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, Executive Vice Chair | Sale of securities on an exchange or to another person at price $ 24.98 per share. | 23 Jan 2024 | 29,956 | 135,441 (0%) | 0% | 25.0 | 748,250 | Common Stock |
| EyePoint Pharmaceuticals Inc | S. Lurker Nancy | Director, Executive Vice Chair | Sale of securities on an exchange or to another person at price $ 24.97 per share. | 23 Jan 2024 | 5,044 | 165,397 (0%) | 0% | 25.0 | 125,950 | Common Stock |
| EyePoint Pharmaceuticals Inc | S. Nancy Lurker | Director, Executive Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 77,000 | 77,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Lurker Nancy S. | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 75,133 | 150,267 | - | - | Restricted Stock Units | |
| EyePoint Pharmaceuticals Inc | Nancy Lurker S. | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 75,133 | 193,484 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharmaceuticals Inc | Lurker Nancy S. | Director, Executive Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 38,000 | 38,000 | - | - | Restricted Stock Units | |
| EyePoint Pharmaceuticals Inc | S. Nancy Lurker | Director, Executive Vice Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.40 per share. | 05 Jan 2024 | 23,043 | 170,441 (0%) | 0% | 20.4 | 470,077 | Common Stock |
| EyePoint Pharmaceuticals Inc | Lurker Nancy S. | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2023 | 52,208 | 52,208 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharmaceuticals Inc | S. Nancy Lurker | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2023 | 52,208 | 118,351 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharmaceuticals Inc | Nancy Lurker S. | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2023 | 35,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Lurker S. Nancy | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2023 | 35,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Lurker Nancy S. | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2023 | 31,164 | 151,370 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | S. Nancy Lurker | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2023 | 31,164 | 62,330 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | S. Lurker Nancy | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2023 | 10,906 | 70,126 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Lurker Nancy S. | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2023 | 10,906 | 4,674 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Lurker S. Nancy | Director, Executive Vice Chair | Sale of securities on an exchange or to another person at price $ 20.76 per share. | 04 Dec 2023 | 20,000 | 170,559 (0%) | 0% | 20.8 | 415,200 | Common Stock |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, Executive Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 66,666 | 66,666 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, Executive Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 33,334 | 33,334 | - | - | Restricted Stock Units | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 225,400 | 225,400 | - | - | Restricted Stock Units | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 120,206 | 93,494 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 120,206 | 120,206 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 75,000 | 165,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 65,868 | 0 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 65,868 | 93,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 59,220 | 15,580 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 59,220 | 59,220 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 36,000 | 0 | - | - | Stock Option (right to buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 36,000 | 54,000 | - | - | Stock Option (right to buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 21,250 | 0 | - | - | Stock Option (right to buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 21,250 | 85,000 | - | - | Stock Option (right to buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 8,000 | 0 | - | - | Stock Option (right to buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2023 | 8,000 | 24,000 | - | - | Stock Option (right to buy) | |
| EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 20,000 | 190,559 (0%) | 0% | 0 | Common Stock |